Cargando…
Vaccination against COVID-19 infection: the need of evidence for diabetic and obese pregnant women
AIM: The recent availability of vaccines against COVID-19 has sparked national and international debate on the feasibility of administering them to pregnant and lactating women, given that these vaccines have not been tested to assess their safety and efficacy in such women. As concerns the risks of...
Autores principales: | Lapolla, A., Dalfrà, M. G., Burlina, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236746/ https://www.ncbi.nlm.nih.gov/pubmed/34181082 http://dx.doi.org/10.1007/s00592-021-01764-0 |
Ejemplares similares
-
Gestational Diabetes Mellitus and Future Cardiovascular Risk: An Update
por: Burlina, S., et al.
Publicado: (2016) -
Genetics and Epigenetics: New Insight on Gestational Diabetes Mellitus
por: Dalfrà, Maria Grazia, et al.
Publicado: (2020) -
Pregnancy after Bariatric Surgery: Nutrition Recommendations and Glucose Homeostasis: A Point of View on Unresolved Questions
por: Burlina, Silvia, et al.
Publicado: (2023) -
Overcoming barriers to COVID-19 vaccination of pregnant women
por: Lamptey, Emmanuel
Publicado: (2022) -
Corticosteroids Use in Pregnant Women with COVID-19: Recommendations from Available Evidence
por: Magala Ssekandi, Abdul, et al.
Publicado: (2021)